12885_2018_4717_MOESM2_ESM.tif (3.62 MB)

Additional file 2: of Low serum gastrin associated with ER+ breast cancer development via inactivation of CCKBR/ERK/P65 signaling

Download (3.62 MB)
posted on 16.08.2018, 05:00 by Li-Li Meng, Jing-Long Wang, Shu-Ping Xu, Li-Dong Zu, Zhao-Wen Yan, Jian-Bing Zhang, Ya-Qin Han, Guo-Hui Fu
Figure S1. Expression of ER, PR, HER2 in 5 primary BC samples. Three primary BC samples were clinically defined as ER+/PR+/HER2− by IHC. Two primary BC samples were clinically defined as TNBC and ER−/PR−/HER2+ by IHC. Case1:HER2−ER+PR+ Case2:HER2−ER+PR+ Case3:HER2−ER+PR+ Case4:HER2−ER−PR−(TNBC) Case5: HER2+ER−PR− Scale bar: 50 μm. (TIF 3702 kb)


National Natural Science Foundation of China